Target intelligence / Profile preview

INTS9 antisense RNA 1 (INTS9-AS1)

Target: INTS9-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

INTS9 antisense RNA 1 (INTS9-AS1) is a human long non-coding RNA gene that lies on the opposite DNA strand of the INTS9 gene. Antisense lncRNAs such as INTS9-AS1 are non-protein-coding transcripts that may regulate the expression of their sense counterparts or participate in diverse regulatory mechanisms within the cell. The detailed biological function, disease implication, and therapeutic relevance of INTS9-AS1 have not yet been established or characterized in the literature.

Other names: INTS9 antisense RNA 1INTS9-AS1ENST00000520055

Mechanism of action

Not applicable, as there are no drugs or direct modulators of this lncRNA reported.

Biological functions

Specific biological functions of INTS9-AS1 are not well characterized or documented in the current literature. As an antisense lncRNA, it may regulate the expression of INTS9 or function in RNA-mediated regulatory processes, but no definitive roles have been established.

Disease associations

No clear disease associations or roles established for INTS9-AS1 so far. There is no evidence for involvement in cancer, inflammation, neurodegenerative disease, or other conditions based on available data.

Safety considerations

None known or documented, as INTS9-AS1 is not a therapeutic target or biomarker.

Interacting drugs

None known. There are no documented drugs that interact with INTS9-AS1.

Biomarkers

None documented. INTS9-AS1 is not currently considered a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on INTS9 antisense RNA 1 (INTS9-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INTS9 antisense RNA 1 (INTS9-AS1).

Explore the full profile